These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 36122624)
1. Sphingomyelinases in retinas and optic nerve heads: Effects of ocular hypertension and ischemia. Fan J; Liu J; Liu J; Angel PM; Drake RR; Wu Y; Fan H; Koutalos Y; Crosson CE Exp Eye Res; 2022 Nov; 224():109250. PubMed ID: 36122624 [TBL] [Abstract][Full Text] [Related]
2. Evidence for ceramide induced cytotoxicity in retinal ganglion cells. Fan J; Liu J; Liu J; Chen C; Koutalos Y; Crosson CE Exp Eye Res; 2021 Oct; 211():108762. PubMed ID: 34499916 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of cytokine signaling in human retinal endothelial cells through downregulation of sphingomyelinases by docosahexaenoic acid. Opreanu M; Lydic TA; Reid GE; McSorley KM; Esselman WJ; Busik JV Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3253-63. PubMed ID: 20071681 [TBL] [Abstract][Full Text] [Related]
4. Suppression of Acid Sphingomyelinase Protects the Retina from Ischemic Injury. Fan J; Wu BX; Crosson CE Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4476-84. PubMed ID: 27571014 [TBL] [Abstract][Full Text] [Related]
5. The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase. Lei X; Zhang S; Bohrer A; Bao S; Song H; Ramanadham S Biochemistry; 2007 Sep; 46(35):10170-85. PubMed ID: 17685585 [TBL] [Abstract][Full Text] [Related]
8. Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase). Kielczewski JL; Li Calzi S; Shaw LC; Cai J; Qi X; Ruan Q; Wu L; Liu L; Hu P; Chan-Ling T; Mames RN; Firth S; Baxter RC; Turowski P; Busik JV; Boulton ME; Grant MB Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8278-86. PubMed ID: 21931131 [TBL] [Abstract][Full Text] [Related]
9. Neutral sphingomyelinase regulates mechanotransduction in human engineered cardiac tissues and mouse hearts. Turner DGP; De Lange WJ; Zhu Y; Coe CL; Simcox J; Ge Y; Kamp TJ; Ralphe JC; Glukhov AV J Physiol; 2024 Sep; 602(18):4387-4407. PubMed ID: 37889115 [TBL] [Abstract][Full Text] [Related]
10. Sphingolipid changes in mouse brain and plasma after mild traumatic brain injury at the acute phases. Mondal K; Del Mar NA; Gary AA; Grambergs RC; Yousuf M; Tahia F; Stephenson B; Stephenson DJ; Chalfant CE; Reiner A; Mandal N Lipids Health Dis; 2024 Jun; 23(1):200. PubMed ID: 38937745 [TBL] [Abstract][Full Text] [Related]
11. Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi. Gu L; Huang B; Shen W; Gao L; Ding Z; Wu H; Guo J J Neuroinflammation; 2013 Sep; 10():109. PubMed ID: 24007266 [TBL] [Abstract][Full Text] [Related]
12. Neutral sphingomyelinase inhibition promotes local and network degeneration in vitro and in vivo. Risner ML; Ribeiro M; McGrady NR; Kagitapalli BS; Chamling X; Zack DJ; Calkins DJ Cell Commun Signal; 2023 Oct; 21(1):305. PubMed ID: 37904133 [TBL] [Abstract][Full Text] [Related]
13. Lack of ceramide synthase 5 protects retinal ganglion cells from ocular hypertensive injury. Liu J; Koutalos Y; Fan J Exp Eye Res; 2024 Oct; 247():110061. PubMed ID: 39182597 [TBL] [Abstract][Full Text] [Related]
14. 27-Hydroxycholesterol inhibits neutral sphingomyelinase in cultured human endothelial cells. Zhou Q; Band MR; Hernandez A; Liu ZL; Kummerow FA Life Sci; 2004 Aug; 75(13):1567-77. PubMed ID: 15261762 [TBL] [Abstract][Full Text] [Related]
15. Multiple pathways originate at the Fas/APO-1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. Cifone MG; Roncaioli P; De Maria R; Camarda G; Santoni A; Ruberti G; Testi R EMBO J; 1995 Dec; 14(23):5859-68. PubMed ID: 8846779 [TBL] [Abstract][Full Text] [Related]
16. Relationships between ocular surface sphingomyelinases, Meibum and Tear Sphingolipids, and clinical parameters of meibomian gland dysfunction. Sanchez V; Galor A; Jensen K; Mondal K; Mandal N Ocul Surf; 2022 Jul; 25():101-107. PubMed ID: 35714913 [TBL] [Abstract][Full Text] [Related]
17. Regulated secretion of acid sphingomyelinase: implications for selectivity of ceramide formation. Jenkins RW; Canals D; Idkowiak-Baldys J; Simbari F; Roddy P; Perry DM; Kitatani K; Luberto C; Hannun YA J Biol Chem; 2010 Nov; 285(46):35706-18. PubMed ID: 20807762 [TBL] [Abstract][Full Text] [Related]
18. Characterization of acidic and neutral sphingomyelinase activities in crude extracts of HL-60 cells. Samet D; Barenholz Y Chem Phys Lipids; 1999 Nov; 102(1-2):65-77. PubMed ID: 11001562 [TBL] [Abstract][Full Text] [Related]
19. Effect of Empagliflozin on Sphingolipid Catabolism in Diabetic and Hypertensive Rats. Pérez-Villavicencio R; Flores-Estrada J; Franco M; Escalante B; Pérez-Méndez O; Mercado A; Bautista-Pérez R Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270028 [TBL] [Abstract][Full Text] [Related]
20. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Samad F; Hester KD; Yang G; Hannun YA; Bielawski J Diabetes; 2006 Sep; 55(9):2579-87. PubMed ID: 16936207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]